Crosstalk between insulin-like growth factors and pro-inflammatory cytokines

[1]  R. Dantzer,et al.  Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice , 2006, Brain, Behavior, and Immunity.

[2]  R. Dantzer,et al.  Pentoxifylline and insulin-like growth factor-I (IGF-I) abrogate kainic acid-induced cognitive impairment in mice , 2005, Journal of Neuroimmunology.

[3]  P. Cohen,et al.  Control of aging and longevity by IGF-I signaling , 2005, Experimental Gerontology.

[4]  A. Kalita,et al.  JAK/STAT3 Pathway Is Involved in Survival of Neurons in Response to Insulin-like Growth Factor and Negatively Regulated by Suppressor of Cytokine Signaling-3* , 2005, Journal of Biological Chemistry.

[5]  A. Wagers,et al.  Cellular and Molecular Signatures of Muscle Regeneration: Current Concepts and Controversies in Adult Myogenesis , 2005, Cell.

[6]  N. Hay,et al.  The Akt-mTOR tango and its relevance to cancer. , 2005, Cancer cell.

[7]  R. Baserga.  The insulin-like growth factor-I receptor as a target for cancer therapy , 2005, Expert opinion on therapeutic targets.

[8]  Francesco Hofmann,et al.  Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. , 2005, Drug discovery today.

[9]  M. Li,et al.  PI3K/Akt‐dependent regulation of the transcription factor myocyte enhancer factor‐2 in insulin‐like growth factor‐1‐ and membrane depolarization‐mediated survival of cerebellar granule neurons , 2005, Journal of neuroscience research.

[10]  J. Sheridan,et al.  Social stress and the regulation of tumor necrosis factor-α secretion , 2005, Brain, Behavior, and Immunity.

[11]  M. Adams,et al.  Functional characterization of des-IGF-1 action at excitatory synapses in the CA1 region of rat hippocampus. , 2005, Journal of neurophysiology.

[12]  R. Loeser,et al.  Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. , 2005, Endocrinology.

[13]  A. Bartke,et al.  Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice , 2005, Neurobiology of Aging.

[14]  P. Ye,et al.  Insulin‐like growth factor‐I protects granule neurons from apoptosis and improves ataxia in weaver mice , 2005, Journal of neuroscience research.

[15]  M. Ranke.  Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance , 2005, Trends in Endocrinology & Metabolism.

[16]  K. Pfeffer,et al.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games , 2005, Immunology.

[17]  J. Brunso-Bechtold,et al.  Differential effects of aging and insulin-like growth factor-1 on synapses in CA1 of rat hippocampus. , 2005, Cerebral cortex.

[18]  Andrew H. Miller,et al.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. , 2005, Viral immunology.

[19]  K. Unsicker,et al.  Insulin-Like Growth Factor 1 Inhibits Extracellular Signal-Regulated Kinase to Promote Neuronal Survival via the Phosphatidylinositol 3-Kinase/Protein Kinase A/c-Raf Pathway , 2005, The Journal of Neuroscience.

[20]  C. Lang,et al.  Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance , 2005, Pediatric Nephrology.

[21]  C. Kenyon.  The Plasticity of Aging: Insights from Long-Lived Mutants , 2005, Cell.

[22]  D. Leroith,et al.  Knock your SOCS off! , 2005, The Journal of clinical investigation.

[23]  H. Wajant,et al.  Tumor therapeutics by design: targeting and activation of death receptors. , 2005, Cytokine & growth factor reviews.

[24]  Carlo Riccardo Rossi,et al.  Tumor necrosis factor, cancer and anticancer therapy. , 2005, Cytokine & growth factor reviews.

[25]  M. Wichers,et al.  Cytokines and major depression , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[26]  J. Harper,et al.  Insulin‐like growth factor ligands, receptors, and binding proteins in cancer , 2005, The Journal of pathology.

[27]  D. Leroith,et al.  Insulin and Insulin-Like Growth Factor I Receptors: Similarities and Differences in Signal Transduction , 2004, Hormone Research in Paediatrics.

[28]  J. Frystyk.  Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[29]  R. Dantzer,et al.  Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide. , 2004, Endocrinology.

[30]  S. Lamberts,et al.  IGF-I and Longevity , 2004, Hormone Research in Paediatrics.

[31]  D. Dunger,et al.  Therapeutic applications of the insulin-like growth factors. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[32]  E. Feldman,et al.  IGF-I prevents glutamate-induced motor neuron programmed cell death , 2004, Neurobiology of Disease.

[33]  R. Dantzer,et al.  IL-1β Suppresses Prolonged Akt Activation and Expression of E2F-1 and Cyclin A in Breast Cancer Cells1 , 2004, The Journal of Immunology.

[34]  R. Dantzer,et al.  IL-1β Impairs Insulin-Like Growth Factor I-Induced Differentiation and Downstream Activation Signals of the Insulin-Like Growth Factor I Receptor in Myoblasts1 , 2004, The Journal of Immunology.

[35]  Prashanth Kenchappa,et al.  Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases. , 2004, Journal of neuroscience research.

[36]  Rémi Quirion,et al.  Comparative signaling pathways of insulin‐like growth factor‐1 and brain‐derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival , 2004, Journal of neurochemistry.

[37]  P. Schulze,et al.  Proinflammatory cytokines and skeletal muscle , 2004, Current opinion in clinical nutrition and metabolic care.

[38]  I. Torres-Aleman,et al.  The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. , 2004, European journal of pharmacology.

[39]  Wenhua Zheng,et al.  Insulin‐like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3k/Akt pathway , 2004, Journal of neuroscience research.

[40]  K. Kelley.  From hormones to immunity: the physiology of immunology , 2004, Brain, Behavior, and Immunity.

[41]  D. Leroith,et al.  The new kid on the block(ade) of the IGF-1 receptor. , 2004, Cancer cell.

[42]  A. Vezzani.  Brain Inflammation and Seizures , 2004, Epilepsy currents.

[43]  R. Dantzer,et al.  Tumor Necrosis Factor α Inhibits Cyclin A Expression and Retinoblastoma Hyperphosphorylation Triggered by Insulin-like Growth Factor-I Induction of New E2F-1 Synthesis* , 2004, Journal of Biological Chemistry.

[44]  R. McCusker,et al.  Zinc partitions IGFs from soluble IGF binding proteins (IGFBP)-5, but not soluble IGFBP-4, to myoblast IGF type 1 receptors. , 2004, The Journal of endocrinology.

[45]  P. Newcomb,et al.  Multifaceted roles of TNF‐α in myoblast destruction: A multitude of signal transduction pathways , 2004, Journal of cellular physiology.

[46]  O. Larsson,et al.  Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell Growth , 2004, Cancer Research.

[47]  F. Peruzzi,et al.  The IGF‐1 receptor in cancer biology , 2003, International journal of cancer.

[48]  M. White.  Insulin Signaling in Health and Disease , 2003, Science.

[49]  R. McCusker,et al.  Zinc partitions insulin‐like growth factors (IGFs) from soluble IGF binding protein (IGFBP)‐5 to the cell surface receptors of BC3H‐1 muscle cells , 2003, Journal of cellular physiology.

[50]  C. Kahn,et al.  Insulin receptor knockout mice. , 2003, Annual review of physiology.

[51]  D. Ishii,et al.  Systemic insulin‐like growth factor‐I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats , 2003, Journal of neuroscience research.

[52]  G. Hotamisligil,et al.  Inflammatory pathways and insulin action , 2003, International Journal of Obesity.

[53]  Anna T Grazul-Bilska,et al.  Wound healing: the role of growth factors. , 2003, Drugs of today.

[54]  G. Martin,et al.  Cell signaling and cancer. , 2003, Cancer cell.

[55]  C. Kahn,et al.  Bi-directional Regulation of Brown Fat Adipogenesis by the Insulin Receptor* , 2003, Journal of Biological Chemistry.

[56]  M. Sheikh,et al.  Death Receptor Activation Complexes: It Takes Two to Activate TNF Receptor 1 , 2003, Cell cycle.

[57]  L. Hennighausen,et al.  Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. , 2003, Cancer research.

[58]  K. Fukunaga,et al.  Akt is a molecular target for signal transduction therapy in brain ischemic insult. , 2003, Journal of pharmacological sciences.

[59]  R. Dantzer,et al.  Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. , 2003, Endocrinology.

[60]  P. Lips,et al.  Insulin-like growth factor I (IGF-I) and cognitive decline in older persons , 2003, Neurobiology of Aging.

[61]  J. Deijen,et al.  Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy , 2003, Psychoneuroendocrinology.

[62]  I. Torres-Aleman,et al.  Brain repair and neuroprotection by serum insulin-like growth factor I , 2003, Molecular Neurobiology.

[63]  C. Lang,et al.  Regulation of insulin-like growth factor-I in skeletal muscle and muscle cells. , 2003, Minerva endocrinologica.

[64]  R. Dantzer,et al.  Cytokine-induced sickness behavior , 2003, Brain, Behavior, and Immunity.

[65]  R. Sapolsky,et al.  Novel glucocorticoid effects on acute inflammation in the CNS , 2003, Journal of neurochemistry.

[66]  H. Cohen,et al.  Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.

[67]  T. Gómez-Isla,et al.  Serum insulin-like growth factor I regulates brain amyloid-β levels , 2002, Nature Medicine.

[68]  B. Ghetti,et al.  Inhibition of insulin‐like growth factor I activity contributes to the premature apoptosis of cerebellar granule neuron in weaver mutant mice: In vitro analysis , 2002, Journal of neuroscience research.

[69]  R. Dantzer,et al.  Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. , 2002, Cancer research.

[70]  A. Yoshimura,et al.  Regulation of cytokine signaling and inflammation. , 2002, Cytokine & growth factor reviews.

[71]  Wenhua Zheng,et al.  Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. , 2002, Molecular pharmacology.

[72]  A. Vezzani,et al.  Functional Role of Inflammatory Cytokines and Antiinflammatory Molecules in Seizures and Epileptogenesis , 2002, Epilepsia.

[73]  J. O’Kusky,et al.  Mutant mouse models of insulin-like growth factor actions in the central nervous system , 2002, Neuropeptides.

[74]  R. Dantzer,et al.  Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior , 2002, Journal of Neuroimmunology.

[75]  W. Murphy,et al.  The role of growth hormone in T‐cell development and reconstitution , 2002, Journal of leukocyte biology.

[76]  Abraham Weizman,et al.  Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson’s disease , 2001, Neuroscience Letters.

[77]  S. Bennett,et al.  Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis , 2001, Neuroscience.

[78]  C. Rommel,et al.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.

[79]  P. Rotwein,et al.  Insulin-like Growth Factor-mediated Muscle Differentiation , 2001, The Journal of Biological Chemistry.

[80]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[81]  I. Torres-Aleman,et al.  Circulating Insulin-Like Growth Factor I Mediates the Protective Effects of Physical Exercise against Brain Insults of Different Etiology and Anatomy , 2001, The Journal of Neuroscience.

[82]  H. Werner,et al.  Regulation of insulin-like growth factor-I receptor gene expression by tumor necrosis factor-α and interferon-γ , 2001, Molecular and Cellular Endocrinology.

[83]  S. Pons,et al.  Insulin-like growth factor I potentiates kainate receptors through a phosphatidylinositol 3-kinase dependent pathway , 2001, Neuroreport.

[84]  A. Bloch,et al.  NF-κB (p65/RelA) as a regulator of TNFα-mediated ML-1 cell differentiation , 2001, Leukemia.

[85]  E. Wouters,et al.  Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor‐κΒ , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  S. Hankinson,et al.  Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. , 2001, The Journal of clinical endocrinology and metabolism.

[87]  J. Coyle,et al.  Insulin‐Like Growth Factor I Prevents the Development of Sensitivity to Kainate Neurotoxicity in Cerebellar Granule Cells , 2000, Journal of neurochemistry.

[88]  W. Lee,et al.  Insulin-like growth factor 1 regulates developing brain glucose metabolism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[89]  Kendra K Bence-Hanulec,et al.  Potentiation of Neuronal L Calcium Channels by IGF-1 Requires Phosphorylation of the α1 Subunit on a Specific Tyrosine Residue , 2000, Neuron.

[90]  S. Tóth,et al.  Autocrine and paracrine regulation by cytokines and growth factors in melanoma. , 2000, Cytokine.

[91]  I. McCutcheon,et al.  The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.

[92]  E. D. de Haan,et al.  Growth hormone, insulin-like growth factor I and cognitive function in adults. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[93]  S. Doré,et al.  Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke. , 2000, Pharmaceutica acta Helvetiae.

[94]  H. Nakanishi,et al.  AMPA–Kainate Subtypes of Glutamate Receptor in Rat Cerebral Microglia , 2000, The Journal of Neuroscience.

[95]  T. Takadera,et al.  Apoptotic Cell Death and Caspase‐3 Activation Induced by N‐Methyl‐d‐Aspartate Receptor Antagonists and Their Prevention by Insulin‐Like Growth Factor I , 1999, Journal of neurochemistry.

[96]  H. Werner,et al.  Tumor necrosis factor α and interferon γ– induced cell growth arrest is mediated via insulin-like growth factor binding protein-3 , 1999 .

[97]  A. Musarò,et al.  Maturation of the Myogenic Program Is Induced by Postmitotic Expression of Insulin-Like Growth Factor I , 1999, Molecular and Cellular Biology.

[98]  D. Kaplan,et al.  Akt-Dependent Potentiation of L Channels by Insulin-Like Growth Factor-1 Is Required for Neuronal Survival , 1999, The Journal of Neuroscience.

[99]  R. Dantzer,et al.  Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. , 1999, Neuroreport.

[100]  R. Dantzer,et al.  The Immune-Endocrine Loop during Aging: Role of Growth Hormone and Insulin-Like Growth Factor-I , 1999, Neuroimmunomodulation.

[101]  M. Pollak,et al.  Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. , 1998, International journal of oncology.

[102]  G. Krupitza,et al.  Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha). , 1998, British Journal of Cancer.

[103]  R. Schwartz,et al.  Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α , 1998 .

[104]  R. McCusker,et al.  Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding. , 1998, Journal of dairy science.

[105]  R. Dantzer,et al.  Activation of Protein Kinase C-ζ and Phosphatidylinositol 3′-Kinase and Promotion of Macrophage Differentiation by Insulin-Like Growth Factor-I , 1998, The Journal of Immunology.

[106]  E. Duda,et al.  TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. , 1997, European journal of cell biology.

[107]  J. Florini,et al.  The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways* , 1997, The Journal of Biological Chemistry.

[108]  G. Rondouin,et al.  Release of TNFα in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage , 1996, Neuroreport.

[109]  Yong Ming Li,et al.  Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I. , 1996, Journal of Immunology.

[110]  Robert J. Schwartz,et al.  Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.

[111]  A. Levitzki,et al.  Tyrosine kinase inhibition: an approach to drug development. , 1995, Science.

[112]  S. Arkins,et al.  The colony-stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis. , 1995, Endocrinology.

[113]  M. Ciotti,et al.  Human recombinant IGF-I induces the functional expression of AMPA/kainate receptors in cerebellar granule cells , 1995, Neuroscience Letters.

[114]  Ziying Liu,et al.  Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. , 1994, Genes & development.

[115]  M. Mattson,et al.  Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis. , 1993, Stroke.

[116]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[117]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[118]  L. Battistini,et al.  Recombinant human insulin-like growth factor I exerts a trophic action and confers glutamate sensitivity on glutamate-resistant cerebellar granule cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[119]  M. Mattson,et al.  IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[120]  R. Dantzer,et al.  Interleukin-1 mediates behavioural but not metabolic effects of tumor necrosis factor α in mice , 1991 .

[121]  M. Dehoff,et al.  Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. , 1991, Endocrinology.

[122]  J. Florini,et al.  Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. , 1991, Molecular endocrinology.

[123]  M. Satoh,et al.  Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and LIF in the rat brain , 1991 .

[124]  J. Miller,et al.  Myogenic programs of mouse muscle cell lines: expression of myosin heavy chain isoforms, MyoD1, and myogenin , 1990, The Journal of cell biology.

[125]  D. Clemmons,et al.  Insulin‐like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs) , 1990, Journal of cellular physiology.

[126]  D. Clemmons,et al.  The insulin-like growth factor-binding proteins of porcine serum: endocrine and nutritional regulation. , 1989, Endocrinology.

[127]  R. McCusker,et al.  Effect of growth hormone-secreting tumours on skeletal muscle cellularity in the rat. , 1986, The Journal of endocrinology.

[128]  E. Feldman,et al.  Insulin-like growth factors in the treatment of neurological disease. , 2005, Endocrine development.

[129]  R. Rosenfeld.  The IGF system: new developments relevant to pediatric practice. , 2005, Endocrine development.

[130]  Zheng‐gang Liu,et al.  Molecular mechanism of TNF signaling and beyond , 2005, Cell Research.

[131]  N. Wilczak,et al.  Insulin-like growth factor system in amyotrophic lateral sclerosis. , 2005, Endocrine development.

[132]  M. Benito,et al.  The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance. , 2005, Acta physiologica Scandinavica.

[133]  G. Dranoff,et al.  Cytokines in cancer pathogenesis and cancer therapy , 2004, Nature Reviews Cancer.

[134]  L. Jarrard.  Use of excitotoxins to lesion the hippocampus: Update , 2002, Hippocampus.

[135]  J. Terwilliger,et al.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. , 2001, Developmental biology.

[136]  G. Müller,et al.  TNF down-regulation of receptor tyrosine kinase-dependent mitogenic signal pathways as an important step in cytostasis induction and commitment to apoptosis of Kym-1 rhabdomyosarcoma cells , 2000, Cell Death and Differentiation.

[137]  A. Brunetti,et al.  Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels. , 1989, The Journal of clinical investigation.